After two senior FDA officials announced their intent to retire, CBER director Dr. Peter Marks will take the reins of the agency’s Office of Vaccines Research and Review.
Marks assumed the role of acting director of the office on Monday.
The departing officials, director of the FDA’s Office of Vaccines Research and Review Dr. Marion Gruber and deputy director Dr. Phil Krause, plan on leaving in October and November, respectively.
In an internal memo dated September 27 obtained by Endpoints News, Marks wrote that he would be “assuming responsibilities as the Acting Office Director, and Marion [Gruber] will transition oversight and management of the activities of the office to me.” The move “will allow Marion and Phil time to transfer their activities and take care of close-out activities prior to departing and help to assure a smooth transition.”
Dr. Peter Marks
T…